Work Here?
Industries
AI & Machine Learning
Biotechnology
Company Size
51-200
Company Stage
Series B
Total Funding
$100.2M
Headquarters
Amsterdam, Netherlands
Founded
2021
Company Does Not Provide H1B Sponsorship
Cradle.bio designs proteins using machine learning, which simplifies a traditionally complex task and allows for faster market entry. The company generates protein sequences with predicted performance scores and continuously improves them through learning from each experimental round. It offers a secure platform where clients retain full ownership of their intellectual property, ensuring data privacy. Cradle.bio aims to provide efficient protein design solutions that help clients achieve their goals more quickly than traditional methods.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$100.2M
Above
Industry Average
Funded Over
3 Rounds
Industry standards
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Company Equity
Professional Development Budget
Remote Work Options
Business and politics must align to drive innovation, particularly in today's technological era where artificial intelligence (AI) is increasingly dominant. The newly launched €150 billion EU AI Champions Initiative marks a significant step forward, with 60 European companies - both startups and Incumbents uniting to streamline AI regulations. Switzerland has a strong representation with four startups and scale-ups supporting the vision of transforming industries with AIThe EU AI Champions Initiative launched at the AI Action Summit in Paris, hosted by French President Emmanuel Macron, aims to position Europe as a global leader in Artificial Intelligence (AI). The initiative will foster collaboration across technology, industry, and policy sectors, boosting AI adoption, talent, investments and innovation to drive Europe’s economic growth and global competitiveness.For the first time, European leaders from across countries, industries, technology, and policy have come together to create a functional flywheel aimed at accelerating Europe's leadership in artificial intelligence. By framing an ambitious and positive vision for Europe, mobilizing talent and capital, and driving AI adoption, this unprecedented collaboration seeks to create self-reinforcing mechanisms that will foster the growth of new technology companies and strengthen the global leadership of Europe’s established industries. Together, they aim to drive economic growth and social prosperity across the continent.The initiative emphasizes the need for a regulatory environment that supports AI innovation while ensuring ethical and secure use of AI technologies
“A lot of foodtech founders in this dry capital environment are beating their heads against the wall with the conviction that the wall will break before their heads do,” observes Paul Shapiro at The Better Meat Co. “That said, deals are still getting done, and important technology is still being developed.”. In some cases, startups have found themselves swimming against the tide, with alt meat getting caught up in the culture wars (spoiler alert: JD Vance does not approve of “disgusting fake meat” and Ron DeSantis has been “fighting back against the global elite’s plan to force the world to eat meat grown in a petri dish”) while the leading player in livestock methane reduction has been battling a barrage of misinformation on social media. In other cases, a confluence of factors has created far more favorable conditions for foodtech startups, however
Cradle, an AI protein-engineering specialist, has received a significant investment. The company uses AI to design proteins, aiming to improve human and planetary health by developing new medicines, sustainable materials, and more. Cradle's platform accelerates R&D projects by 1.2 to 12 times and reduces costs by up to 90%. Since commercialization, it has gained over 21 clients and is developing 31 proteins.
💰 I'm proud to announce that one year after announcing our Series A, we have now raised a $73M Series B led by IVP, with continued backing from Index Ventures… | 128 comments on LinkedIn
Cradle, a protein-engineering specialist from Delft, has received significant investment. The company uses AI to design proteins, aiming to improve human and planetary health by creating new medicines, sustainable materials, and more. Cradle's platform accelerates R&D projects by 1.2 to 12 times and reduces costs by up to 90%. Since commercialization, it has gained over 21 clients and is developing 31 proteins, with a customer satisfaction score of 8+.
Find jobs on Simplify and start your career today
Industries
AI & Machine Learning
Biotechnology
Company Size
51-200
Company Stage
Series B
Total Funding
$100.2M
Headquarters
Amsterdam, Netherlands
Founded
2021
Find jobs on Simplify and start your career today